Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Jonathan David Campbell

TitleAssociate Professor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOP-Administration
Phone303/724-2886
    Other Positions
    TitleDirector-Faculty
    InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
    DepartmentSOP-Administration


    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Whittington MD, Kempe A, Dempsey A, Herlihy R, Campbell JD. Impact of Nonmedical Vaccine Exemption Policies on the Health and Economic Burden of Measles. Acad Pediatr. 2017 Mar 09. PMID: 28286295.
      View in: PubMed
    2. Whittington MD, Curtis DJ, Atherly AJ, Bradley CJ, Lindrooth RC, Campbell JD. Screening test recommendations for methicillin-resistant Staphylococcus aureus surveillance practices: A cost-minimization analysis. Am J Infect Control. 2017 Jan 23. PMID: 28126259.
      View in: PubMed
    3. Dilokthornsakul P, Valuck RJ, Nair KV, Corboy JR, Allen RR, Campbell JD. Multiple sclerosis prevalence in the United States commercially insured population. Neurology. 2016 Mar 15; 86(11):1014-21. PMID: 26888980; PMCID: PMC4799713 [Available on 03/15/17].
    4. McQueen RB, Breton MD, Ott M, Koa H, Beamer B, Campbell JD. Economic Value of Improved Accuracy for Self-Monitoring of Blood Glucose Devices for Type 1 Diabetes in Canada. J Diabetes Sci Technol. 2015 Aug 14; 10(2):366-77. PMID: 26275642; PMCID: PMC4773951.
    5. Leppert MH, Campbell JD, Simpson JR, Burke JF. Cost-Effectiveness of Intra-Arterial Treatment as an Adjunct to Intravenous Tissue-Type Plasminogen Activator for Acute Ischemic Stroke. Stroke. 2015 Jul; 46(7):1870-6. PMID: 26012639; PMCID: PMC4480156.
    6. Haukoos JS, Hopkins E, Bucossi MM, Lyons MS, Rothman RE, White DA, Al-Tayyib AA, Bradley-Springer L, Campbell JD, Sabel AL, Thrun MW. Brief report: Validation of a quantitative HIV risk prediction tool using a national HIV testing cohort. J Acquir Immune Defic Syndr. 2015 Apr 15; 68(5):599-603. PMID: 25585300; PMCID: PMC4357562.
    7. McQueen RB, Livingston T, Vollmer T, Corboy J, Buckley B, Allen RR, Nair K, Campbell JD. Increased relapse activity for multiple sclerosis natalizumab users who become nonpersistent: a retrospective study. J Manag Care Spec Pharm. 2015 Mar; 21(3):210-8b. PMID: 25726030.
      View in: PubMed
    8. Campbell JD, McQueen RB, Libby AM, Spackman DE, Carlson JJ, Briggs A. Cost-Effectiveness Uncertainty Analysis Methods: A Comparison of One-Way Sensitivity, Analysis of Covariance, and Expected Value of Partial Perfect Information. Med Decis Making. 2015 Jul; 35(5):596-607. PMID: 25349188.
      View in: PubMed
    9. MacLaren R, Campbell J. Cost-effectiveness of histamine receptor-2 antagonist versus proton pump inhibitor for stress ulcer prophylaxis in critically ill patients*. Crit Care Med. 2014 Apr; 42(4):809-15. PMID: 24365863.
      View in: PubMed
    10. McQueen RB, Ellis SL, Maahs DM, Anderson HD, Nair KV, Libby AM, Campbell JD. Association between glycated hemoglobin and health utility for Type 1 diabetes. Patient. 2014; 7(2):197-205. PMID: 24458545.
      View in: PubMed
    11. Slejko JF, Ho M, Anderson HD, Nair KV, Sullivan PW, Campbell JD. Adherence to statins in primary prevention: yearly adherence changes and outcomes. J Manag Care Pharm. 2014 Jan; 20(1):51-7. PMID: 24372460.
      View in: PubMed
    12. Haukoos JS, Campbell JD, Conroy AA, Hopkins E, Bucossi MM, Sasson C, Al-Tayyib AA, Thrun MW. Programmatic cost evaluation of nontargeted opt-out rapid HIV screening in the emergency department. PLoS One. 2013; 8(12):e81565. PMID: 24391706; PMCID: PMC3877399.
    13. Campbell JD, Ghushchyan V, Brett McQueen R, Cahoon-Metzger S, Livingston T, Vollmer T, Corboy J, Miravalle A, Schreiner T, Porter V, Nair K. Burden of multiple sclerosis on direct, indirect costs and quality of life: National US estimates. Mult Scler Relat Disord. 2014 Mar; 3(2):227-36. PMID: 25878010.
      View in: PubMed
    14. Smith SM, Campbell JD. Cost-effectiveness of renin-guided treatment of hypertension. Am J Hypertens. 2013 Nov; 26(11):1303-10. PMID: 24048147.
      View in: PubMed
    15. Belozeroff V, Lee A, Tseng S, Chiroli S, Campbell JD. Cost per responder analysis in patients with secondary hyperparathyroidism on dialysis treated with cinacalcet. J Med Econ. 2013 Sep; 16(9):1154-62. PMID: 23869940.
      View in: PubMed
    16. Campbell JD, McQueen RB, Miravalle A, Corboy JR, Vollmer TL, Nair K. Comparative effectiveness of early natalizumab treatment in JC virus-negative relapsing-remitting multiple sclerosis. Am J Manag Care. 2013 Apr; 19(4):278-85. PMID: 23725360.
      View in: PubMed
    17. Campbell JD, Zerzan J, Garrison LP, Libby AM. Comparative-effectiveness research to aid population decision making by relating clinical outcomes and quality-adjusted life years. Clin Ther. 2013 Apr; 35(4):364-70. PMID: 23477685.
      View in: PubMed
    18. MacLaren R, Brett McQueen R, Campbell J. Clinical and financial impact of pharmacy services in the intensive care unit: pharmacist and prescriber perceptions. Pharmacotherapy. 2013 Apr; 33(4):401-10. PMID: 23468188.
      View in: PubMed
    19. Yamamoto D, Campbell JD. Cost-effectiveness of multiple sclerosis disease-modifying therapies: a systematic review of the literature. Autoimmune Dis. 2012; 2012:784364. PMID: 23304459; PMCID: PMC3523130.
    20. Libby AM, Ghushchyan V, McQueen RB, Slejko JF, Bainbridge JL, Campbell JD. Economic differences in direct and indirect costs between people with epilepsy and without epilepsy. Med Care. 2012 Nov; 50(11):928-33. PMID: 23047781.
      View in: PubMed
    21. Slejko JF, Libby AM, Nair KV, Valuck RJ, Campbell JD. Pharmacoeconomics and outcomes research degree-granting PhD programs in the United States. Res Social Adm Pharm. 2013 Jan-Feb; 9(1):108-13. PMID: 22554392.
      View in: PubMed
    22. Akinbami LJ, Sullivan SD, Campbell JD, Grundmeier RW, Hartert TV, Lee TA, Smith RA. Asthma outcomes: healthcare utilization and costs. J Allergy Clin Immunol. 2012 Mar; 129(3 Suppl):S49-64. PMID: 22386509; PMCID: PMC4277846.
    23. Campbell JD, Allen-Ramey F, Sajjan SG, Maiese EM, Sullivan SD. Increasing pharmaceutical copayments: impact on asthma medication utilization and outcomes. Am J Manag Care. 2011 Oct; 17(10):703-10. PMID: 22106463.
      View in: PubMed
    24. McQueen RB, Ellis SL, Campbell JD, Nair KV, Sullivan PW. Cost-effectiveness of continuous glucose monitoring and intensive insulin therapy for type 1 diabetes. Cost Eff Resour Alloc. 2011 Sep 14; 9:13. PMID: 21917132; PMCID: PMC3180394.
    25. Campbell JD. Managed care opportunities for improving asthma care. Am J Manag Care. 2011 Apr; 17 Suppl 3:S90-6. PMID: 21761959.
      View in: PubMed
    26. Libby AM, Ghushchyan V, McQueen RB, Campbell JD. Economic grand rounds: psychological distress and depression associated with job loss and gain: the social costs of job instability. Psychiatr Serv. 2010 Dec; 61(12):1178-80. PMID: 21123399.
      View in: PubMed
    27. Watanabe JH, Campbell JD, Ravelo A, Chancellor MB, Kowalski J, Sullivan SD. Cost analysis of interventions for antimuscarinic refractory patients with overactive bladder. Urology. 2010 Oct; 76(4):835-40. PMID: 20430422.
      View in: PubMed
    28. Campbell JD, Spackman DE, Sullivan SD. The costs and consequences of omalizumab in uncontrolled asthma from a USA payer perspective. Allergy. 2010 Sep; 65(9):1141-8. PMID: 20148804.
      View in: PubMed
    29. Hollingworth W, Campbell JD, Kowalski J, Ravelo A, Girod I, Briggs A, Sullivan SD. Exploring the impact of changes in neurogenic urinary incontinence frequency and condition-specific quality of life on preference-based outcomes. Qual Life Res. 2010 Apr; 19(3):323-31. PMID: 20094804.
      View in: PubMed
    30. Campbell JD, Gries KS, Watanabe JH, Ravelo A, Dmochowski RR, Sullivan SD. Treatment success for overactive bladder with urinary urge incontinence refractory to oral antimuscarinics: a review of published evidence. BMC Urol. 2009 Nov 20; 9:18. PMID: 19930578; PMCID: PMC2788579.
    31. Campbell JD, Ramsey SD. The costs of treating breast cancer in the US: a synthesis of published evidence. Pharmacoeconomics. 2009; 27(3):199-209. PMID: 19354340.
      View in: PubMed
    32. Campbell JD, Spackman DE, Sullivan SD. Health economics of asthma: assessing the value of asthma interventions. Allergy. 2008 Dec; 63(12):1581-92. PMID: 19032230.
      View in: PubMed
    33. Campbell JD, Blough DK, Sullivan SD. Comparison of guideline-based control definitions and associations with outcomes in severe or difficult-to-treat asthma. Ann Allergy Asthma Immunol. 2008 Nov; 101(5):474-81. PMID: 19055200.
      View in: PubMed
    34. Campbell JD, Borish L, Haselkorn T, Rasouliyan L, Lee JH, Wenzel SE, Sullivan SD. The response to combination therapy treatment regimens in severe/difficult-to-treat asthma. Eur Respir J. 2008 Nov; 32(5):1237-42. PMID: 18684845.
      View in: PubMed
    Campbell's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _

    Copyright © 2017 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.10.0)